Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: A double-blind, randomised controlled trial

On behalf of the VX11-770-110 (KONDUCT) Study Group

Research output: Contribution to journalArticlepeer-review

175 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: A double-blind, randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences